Repros Therapeutics, Inc. (RPRX) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $60.18 +1.23%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q4 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $1 thousand.
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
For earnings history and earnings-related data on Repros Therapeutics, Inc. (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Palogic urges Granite Point Mortgage to cut costs, halt new loans
- GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
